Table 3. Asymmetric plasma membrane composition.
Fatty acid tails abbreviated as FA.
| Lipid | FA | Full name | Charge | Inner leaflet [mol %] | Outer leaflet [mol %] |
|---|---|---|---|---|---|
| CHOL | Cholesterol | 0 | 40.4 | 40.0 | |
| PSM | 18:1/16:0 | N-palmitoyl-D-erythro-sphingosylphosphorylcholine | 0 | 1.0 | 12.0 |
| NSM | 18:1/24:1 | N-nervonoyl-D-oleoyl-sphingosylphosphorylcholine | 0 | - | 9.0 |
| LSM | 18:1/24:0 | N-lignoceroyl-D-oleoyl-sphingosylphosphorylcholine | 0 | - | 8.0 |
| PLPC | 16:0/18:2 | 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine | 0 | 8.1 | 15.0 |
| SOPC | 18:0/18:1 | 1-stearoyl-2-oleoylphosphocholine | 0 | - | 7.0 |
| PAPC | 16:0/20:4 | 1-palmitoyl-2-arachidonoyl-glycero-3-phosphocholine | 0 | - | 5.0 |
| POPC | 16:0/18:1 | 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine | 0 | 3.0 | - |
| DPPC | 16:0/16:0 | 1,2-dipalmitoyl-glycero-3-phosphocholine | 0 | 2.0 | - |
| PLA20(PE) | 18:0/20:4 | 1-O-stearoyl-2-O-arachidonoyl-glycero-3-phosphoethanolamine | 0 | 11.1 | 3.0 |
| PDoPE | 16:0/22:6 | 1-palmitoyl-2-docosahexaenoyl-glycero-3-phosphoethanolamine | 0 | 8.1 | - |
| SAPE | 18:0/20:4 | 1-stearoyl-2-arachidonoyl-glycero-3-phosphoethanolamine | 0 | 4.0 | - |
| POPE | 16:0/18:1 | 1-palmitoyl-2-oleoyl-glycero-3-phosphoethanolamine | 0 | 3.0 | - |
| PAPS | 16:0/20:4 | 1-palmitoyl-2-arachidonoyl-glycero-3-phosphoserine | -1 | 13.1 | - |
| SAPS | 18:0/20:4 | 1-stearoyl-2-arachidonoyl-glycero-3-phosphoserine | -1 | 1.0 | 1.0 |
| PI(4,5)P2 | 16:0/18:2 | 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphoinositol-4,5-bisphosphate | -4 | 5.1 | - |